People line up to take a nucleic acid test for the coronavirus disease (COVID-19) at a testing booth in Beijing on November 15. Photo: Reuters
People line up to take a nucleic acid test for the coronavirus disease (COVID-19) at a testing booth in Beijing on November 15. Photo: Reuters
IPO

China pledges to carefully vet Covid-testing companies in IPO pipeline amid concerns about earnings outlook

  • Statement by Shanghai and Shenzhen bourses came after local media questioned lax approvals for such IPOs given limited growth prospects
  • At least four such companies have applied to list on the ChiNext board in Shenzhen

People line up to take a nucleic acid test for the coronavirus disease (COVID-19) at a testing booth in Beijing on November 15. Photo: Reuters
People line up to take a nucleic acid test for the coronavirus disease (COVID-19) at a testing booth in Beijing on November 15. Photo: Reuters
READ FULL ARTICLE